Australian Life Sciences Stock News

Central banks are signalling that interest rates may stay higher for longer as they watch inflation and bond markets closely. For income seekers this keeps the spotlight on what can be earned from portfolios right now. Reliable dividend income becomes more valuable when cash yields might not rise much further. This article picks out three stocks from the Dividend Powerhouses screener that offer yields above 5% with covered, growing payouts. The stocks covered below are just a small sample...

Energy led inflation remains a live theme for central banks, with policy paths described as uncertain but balanced. That kind of backdrop often keeps investors focused on risk, yet it can also draw attention to penny stocks with stronger balance sheets and healthier cash profiles. This article looks at three Financially Fit Penny Stocks from our screener that aim to pair cautious optimism with disciplined financial foundations. The stocks highlighted below are just a sample, with the full...

Energy prices are back in focus as oil holds firm on Middle East developments, which keeps inflation and interest rate expectations in play. That mix can put pressure on weaker companies and highlight businesses with solid balance sheets and clear earnings growth paths. This article highlights 3 stocks from the Healthy high growth potential screener that analysts expect to deliver strong earnings growth with acceptable financial strength. The three stocks below are just a sample from this...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Some of the losses seen by insiders who purchased AU$2.88m worth of Kinetiko Energy Limited ( ASX:KKO ) shares over the...

Count Limited ( ASX:CUP ) insiders who bought shares over the past year were rewarded handsomely last week. The stock...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Investors who take an interest in Control Bionics Limited ( ASX:CBL ) should definitely note that insider Stephen Rix...

As the S&P/ASX 200 index is set to open lower, mirroring Wall Street's overnight declines amid rising oil prices and geopolitical tensions, investors are closely monitoring market movements and economic indicators. In this environment of cautious optimism, growth companies with high insider ownership can offer a compelling investment narrative, as they often align management interests with shareholder value while potentially delivering substantial earnings growth.

As the S&P/ASX 200 index prepares to open lower, mirroring declines on Wall Street amid rising oil prices and geopolitical tensions, investors are closely monitoring the Reserve Bank of Australia's decision to maintain interest rates at 4.35%. In this context of economic uncertainty and fluctuating commodity prices, identifying stocks that may be trading below their estimated value can provide strategic opportunities for investors seeking potential growth in a challenging market environment.

The S&P/ASX 200 index is expected to open lower, reflecting overnight declines on Wall Street as oil prices continue to rise and investors digest the Reserve Bank of Australia's decision to maintain interest rates at 4.35%. Amid these market dynamics, penny stocks remain a topic of interest for investors seeking growth opportunities. Although the term 'penny stocks' might seem outdated, these smaller or newer companies can offer significant potential when supported by strong financials.

Bond markets are reacting sharply to changing policy and growth expectations, which keeps income hungry investors guessing about where to find reliable yield. That is where Dividend Fortresses stocks come in. These high yielders focus on consistency when markets feel driven by headlines. This article walks through three Dividend Fortresses candidates that combine 5%+ yields with balance sheet resilience so readers can evaluate whether they fit a long term income plan. The stocks in the list...

Suncorp Group Limited (ASX:SUN) has announced an A$250 million on-market share buyback funded from cash, alongside a fully franked 52 cent final dividend and 10 cent special dividend for the year ended 30 June 2026, and reported full-year net profit of A$1.03 billion, down from A$1.82 billion a year earlier. The company also outlined executive reshuffles to sharpen its focus on customer, brand and digital capabilities, and confirmed Ernst & Young as preferred external auditor from the 2027...

Australian Foundation Investment Company Limited recently reported an estimated pre-tax net tangible asset backing of A$8.19 per share as at 7 August 2026, incorporating provisions for a final dividend of 14.5 cents and a special dividend of 2.5 cents per share. This update gives investors a clearer view of the relationship between the company’s underlying asset backing and the cash being returned through dividends. Next, we’ll consider how this updated NTA estimate, together with the...

Commonwealth Bank of Australia recently reported higher full-year net interest income of A$25,586 million and net income of A$10,866 million to June 30, 2026, alongside a fully franked final dividend of A$2.70 per share and completion of a A$316.84 million share buyback program representing 0.17% of its capital. At the same time, the bank highlighted a 15% fall in mortgage applications after tax and rate changes, even as its home loan market share and broker-originated flows increased, and...

Fortescue stock reacts to electric haul truck deal news Interest in Fortescue (ASX:FMG) has picked up after news that XCMG will supply 150 to 200 battery electric haul trucks for its Pilbara operations, in line with Fortescue’s aim to cut fossil fuel use by 2030. See our latest analysis for Fortescue. Set against this electric haul truck agreement, Fortescue’s share price has eased, with a 30 day share price return down 4.32% and a 90 day share price return down 21.88%. The 5 year total...

Pro Medicus (ASX:PME) has announced a 7 year A$23 million contract with St. Luke's Health System in Boise, Idaho, to deploy its Visage 7 Enterprise Imaging Platform across the network. See our latest analysis for Pro Medicus. The latest contract win comes after a mixed year for Pro Medicus, with the share price at A$181.67 and recent momentum easing over the past month, even as the 90 day share price return is up 49.4% and the 3 year total shareholder return is 161.94%. If this St. Luke's...

Aeris Resources (ASX:AIS) has drawn fresh attention after issuing its fiscal 2027 production guidance and flagging higher growth capital, alongside an upcoming presentation at the Diggers & Dealers Mining Forum on 5 August 2026. See our latest analysis for Aeris Resources. The latest production outlook and the upcoming Diggers & Dealers presentation have arrived alongside a 14.67% one-month share price return for Aeris Resources. However, the share price is still down 25.86% year to date and...

Oil prices tied to Middle East risk are in focus again, which keeps inflation and interest rate expectations in play. That backdrop makes investors look harder at themes that do not rely only on cheap capital or broad economic momentum. Transformative AI healthcare stocks fit that search for structural growth drivers. This article highlights three stocks from the Transformative AI Healthcare Stocks screener that stand out for further research. The three stocks below are a focused sample. The...

Southern Cross Media Group walked into this result with a flat 7 day share price and only a modest 30 day gain, hardly the setup for drama. The headline was a sharp squeeze on profit. Net profit after tax slipped to A$9.9m as merger and restructuring charges bit into what was otherwise an earnings reset story. The market now faces a sentiment reckoning. Do you price the stock off the cleaner A$200m of earnings before interest, tax, depreciation and amortisation, or do you fixate on the...

AGL Energy Limited has reported past full-year results for the period ended June 30, 2026, with sales of A$13,590 million compared with A$14,339 million a year earlier, while net income rose to A$756 million from A$112 million. Despite the lower sales, the uplift in basic earnings per share from continuing operations to A$1.124 from A$0.167 highlights a significant improvement in profitability and cost management. Now we will explore how this sharp rise in annual net income, despite softer...

Coronado Global Resources just served up a sharper earnings story than its share price suggests. The stock closed at A$0.16 on 11 August, after a steep 7 day slide and a heavy 90 day fall, yet the latest quarter shows a smaller earnings loss and stronger top line than recent history. The headline is the margin squeeze easing rather than exploding. Revenue reached US$514.1m in Q2 while the net loss narrowed to US$99.4m. The market is still trading Coronado like a broken story, even as the P&L...

Chrysos stock comes into this earnings read on a strong run, with the shares up about 41% over the past month and sitting at A$7.78 at the last close. That kind of run up suggests that expectations were already intense. The headline from the FY26 result is simple. Chrysos is now a profitable, cash-generative assay technology business with revenue of about A$88.1m and earnings from continuing operations of A$1.79m over the last twelve months. The emotional tug of a high P/S of 10.2x now...

Helia Group walked into this result with the stock at A$6.04 and a solid run over the past quarter, yet the story the half year tells is more nuanced than a simple price chart. The headline is that Helia is still minting sizeable profits from its in force mortgage insurance portfolio, with A$100m in net income for the first half of 2026 and a reported return on equity near 22%. At the same time, investors now need to square those strong margins with softer new business volumes and a high...